BAUSCH HEALTH COMPANIES WKN: A2JQ1X ISIN: CA0717341071 Kürzel: BHC Forum: Aktien Thema: Hauptdiskussion

Morgen kommen die zahlen oder ?

https://ir.bauschhealth.com/events-and-presentations/2020

https://pub.webull.com/us/news-html/aebd4e78daf84bb4a60d0b2fc23ac67e.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en

Bausch Health Initiates VIRAZOLE® (Ribavirin for Inhalation Solution, USP) Clinical Study in Patients with COVID-19 April 13, 2020 Bausch Health Is Working with Multiple Health Authorities to Make VIRAZOLE Available as a Potential Treatment for COVID-19 LAVAL, Quebec, April 13, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it has initiated a clinical trial program in Canada evaluating an investigational use of VIRAZOLE® (Ribavirin for Inhalation Solution, USP) in combination with standard of care therapy to treat hospitalized adult patients with respiratory distress due to COVID-19. Because ribavirin is a synthetic nucleoside that works to stop viral replication, VIRAZOLE may be effective in reducing the severity of COVID-19 infection. VIRAZOLE is currently approved in several countries around the world, including the United States and Canada, for the treatment of hospitalized infants and young children with severe lower respiratory tract infections due to respiratory syncytial virus (RSV). The initial clinical study has been approved by Health Canada and is expected to begin within the next few weeks. The Company is also in discussions with the U.S. Food and Drug Administration and health authorities in multiple countries regarding additional studies to evaluate VIRAZOLE as a treatment for COVID-19 infection. The Bausch Foundation is also continuing to work directly with health authorities in Italy to make VIRAZOLE for inhalation available free of charge in compassionate use in Italian hospitals. "VIRAZOLE has demonstrated antiviral activity in treating severe pediatric respiratory infections, and we believe it may be a valuable agent in reducing respiratory distress in adults suffering from COVID-19. We are actively pursuing approval of our trial protocol around the world to test the efficacy and safety of VIRAZOLE in this patient population," said Joseph C. Papa, chairman and CEO, Bausch Health. "Bausch Health will remain focused – for as long as necessary – on doing our part to help end this unprecedented global health pandemic, including donating our health care products, conducting research to find new treatment options and supporting patients, health care providers and our employees." The initial study protocol is an open label, interventional trial that will evaluate the safety and efficacy of VIRAZOLE in hospitalized adult patients, aged 18 or older, who have tested positive for COVID-19, and as a result of their infection, have significant respiratory distress. Two active study arms will compare different dosing regimens of VIRAZOLE in combination with standard of care therapy. More details on the study can be found on theHealth Canada Clinical Trials Database and onHealth Canada COVID-19 List of Clinical Trials

https://eyewire.news/articles/bausch-health-donates-health-care-products-and-supplies-in-response-to-covid-19-pandemic/

Stellt Bausch eigentlich aktuell auch Medizinisches Schutzmaterial her??

Dort Money ist eine Auszeichnung für Bausch Health, stellt euch eine Tankstelle vor die ihr Benzin im 4000% erhöht, man würde sie auslachen.

Ja kenne ich... aktuell finde ich aber pandemic sehr interessant... ebenfalls auf Netflix. Trotz Pandemieplan hat die westliche Welt alles falsch gemacht.

Sorry..Staffel 1 Folge 3....Teure Medizin

Wem es interessiert..auf Netflix die Serie ,Dirty Money‘ Geld regiert die Welt..Staffel 2 Folge 1.. da geht’s um die Machenschaften von Pearson und Valeant 🙈

Wird Zeit, dass Bausch was gegen Corona herausbringet.....dann sehen wir die 200

Puh, Bausch hat echt verhältnismäßig sehr viele Federn gelassen :(

Using cash generated from operations, Bausch Health Companies (NYSE:BHC) will reduce its senior secured loans by ~$100M next week. After this prepayment, the company will have no further mandatory amortization payments until 2022. Shares up 4% premarket on light volume.

Nerfi, in China. Da gehen die Neuinfizierten anscheinend zurück. Bei uns hingegen fängt es an. Am besten du beobachtest die täglichen Zahlen beim Robert Koch Institut. Q Da gibt es 1-2x täglich aktuelle Zahlen, natürlich ohne Dunkelziffer. Wir sind in Deutschland bzw Europa erst am Anfang.

Ja da kann ich wirklich mal den Podcast mit Dr. Drosten vom Ndr zum Thema Corona empfehlen. Höre es mir über YouTube an. Der ist so herrlich sachlich und nüchtern.

Und genau diese Tatsache verunsichert die Menschen. Wir erleben hier den gleichen Herdentrieb wie beim Hamsterkauf in den Supermärkten.